Le Lézard
Classified in: Health
Subjects: RCL, PSF, CFG

Quaker Recall Leads to Canada-Wide Class Action


VANCOUVER, BC, Jan. 19, 2024 /CNW/ - Slater Vecchio LLP has filed a class action lawsuit in British Columbia against The Quaker Oats Company and PepsiCo Canada ULC on behalf of all persons in Canada who purchased or claim to have fallen ill from consuming Quaker products that have been recalled due to potential Salmonella contamination.

On January 11, 2024, the Canadian Food Inspection Agency recalled thirty-eight Quaker products, including Quaker-branded granola and cereal products, due to possible Salmonella contamination. The Canadian Food Inspection Agency subsequently recalled over thirty yogurt and parfait products that contained recalled Quaker granola. A full list of the products recalled as of January 16, 2024 is accessible on the Government of Canada's recall database.

Sam Jaworski, a partner at Slater Vecchio LLP, stated, "Canadians trust manufacturers to produce packaged foods that can safely be consumed without the risk of illness from contamination. Through a class action, Canadians can access justice to hold suppliers accountable through strength in numbers, even if it would not be economical to pursue a lawsuit at the individual level."

If you suspect that you have fallen ill after eating a potentially contaminated product, seek medical attention as appropriate. If you have purchased but have not yet consumed a recalled product, follow Health Canada's guidance and either discard the product or return it to the location from where you purchased it.

Slater Vecchio LLP is seeking to identify individuals who fell ill from consuming a recalled product. Please submit your information on our website at https://www.slatervecchio.com/class-action/quaker-granoloa-salmonella-class-action/.

SOURCE Slater Vecchio LLP


These press releases may also interest you

at 06:20
Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced initial safety and tolerability data from its ongoing Phase 1/2 gene therapy...

at 06:10
Broken String Biosciences ("Broken String"), a genomics company driving development of the next generation of more precise, safe, and effective cell and gene therapies, today announced it has entered a research collaboration with the Francis Crick...

at 06:05
Excellos Inc., a cell therapy contract and development manufacturing organization (CDMO), today announced it had taken additional investment to accelerate commercialization efforts. As part of the change new CEO Thomas VanCott, Ph.D., will step in to...

at 06:05
Allianz Trade, the world's leading trade credit insurer and Inclusive Brains, a French start-up developing a new generation of neural interfaces powered by generative Artificial Intelligence (AI), have partnered to develop Prometheus, a new kind of...

at 06:05
Aurinia Pharmaceuticals Inc. (Aurinia or the Company) today announced that it will attend the 2024 RBC Capital Markets Global Healthcare Conference in New York from May 14-15, 2024. Aurinia management will host one-on-one meetings with investors...

at 06:05
Biodesix, Inc. , a leading diagnostic solutions company with a focus in lung disease, announced today that Scott Hutton, Chief Executive Officer of Biodesix, will present and host in-person 1x1 investor meetings at the 2024 RBCCM Global Healthcare...



News published on and distributed by: